9.29 0.00 (0.00%)
After hours: 4:00PM EDT
Previous Close | 9.37 |
Open | 9.34 |
Bid | 8.55 x 600 |
Ask | 15.00 x 100 |
Day's Range | 9.06 - 9.46 |
52 Week Range | 5.87 - 19.30 |
Volume | 74,997 |
Avg. Volume | 240,922 |
Market Cap | 236.342M |
Beta | 0.27 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.84 |
Earnings Date | May 8, 2018 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.60 |
NanoString Technologies Inc (NASDAQ:NSTG) is a small-cap stock with a market capitalization of US$244.74M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, theyRead More...
NEW YORK, April 18, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
SEATTLE, April 12, 2018-- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced a record number of abstracts that ...
SEATTLE, April 10, 2018-- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of the Breast Cancer 360™ ...
SEATTLE, April 09, 2018-- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release first ...
NEW YORK, March 29, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Q4 2017 NanoString Technologies Inc Earnings Call
The Seattle-based company said it had a loss of 34 cents per share. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a ...
SEATTLE, March 07, 2018-- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the fourth quarter ...
NEW YORK, NY / ACCESSWIRE / March 7, 2018 / NanoString Technologies, Inc. (NASDAQ: NSTG ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 7, 2018, at 4:30 PM Eastern ...
NanoString Technologies Inc (NASDAQ:NSTG), a life sciences company based in United States, received a lot of attention from a substantial price movement on the NasdaqGM in the over the lastRead More...
SEATTLE, March 06, 2018-- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’ s management is ...
SEATTLE, Feb. 21, 2018-- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release fourth ...
Digital Spatial Profiling Demonstrates Profiling of Proteins and 1,000+ mRNAs Across Multiple Regions from FFPE Tissue Sections using Next Generation Sequencing Readout. First Customer Data Using Hyb & ...
Comprehensive Study Includes All Danish Women Diagnosed with Breast Cancer from 2000 to 2003 who were Indicated for Prosigna and Treated with Endocrine Therapy. Accompanying Editorial Highlights Encouraging ...
NEW YORK, Jan. 26, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NanoString ...
Assessing NanoString Technologies Inc’s (NASDAQ:NSTG) past track record of performance is an insightful exercise for investors. It allows us to reflect on whether or not the company has met orRead More...